References
Alama, A.; Barbieri, F.; Favre, A., et al. Establishment and characterization of three new cell lines derived from the ascites of human ovarian carcinomas. Gynecol. Oncol. 62:82–88; 1996.
Bast, R. C., Jr.; Feeney, M.; Lazarus, H., et al. Reactivity of a monoclonal antibody with human ovarian carcinoma. J. Clin. Invest. 68:1331–1337; 1981.
Bocker, T.; Diermann, J.; Friedl, W., et al. Microsatellite instability analysis: a multicenter study for reliability and quality control. Cancer Res. 57:4739–4743; 1997.
Buick, R. N.; Pullano, R.; Trent, J. M. Comparative properties of five human ovarian adenocarcinoma cell lines. Cancer Res. 45:3668–3676; 1985.
Buller, R. E.; Niemann, T.; Connor, J. P., et al. Isolation and preliminary characterization of an ovarian carcinoma cell line from a patient with familial ovarian cancer. Gynecol. Oncol. 56:39–44; 1995.
Crickard, K.; Niedbala, M. J.; Crickard, U., et al. Characterization of human ovarian and endometrial carcinoma cell lines established on extracellular matrix. Gynecol. Oncol. 32:163–173; 1989.
DiSaia, P. J.; Morrow, M.; Kanabus, J., et al. Two new tissue culture lines from ovarian cancer. Oncology 3:215–219; 1975.
Easton, D. F.; Bishop, D. T.; Ford, D., et al. Genetic linkage analysis in familial breast and ovarian cancer: results from 214 families. The breast cancer linkage consortium. Am. J. Hum. Genet. 52:678–701; 1993.
Fogh, J.; Trempe, G. New human tumor cell lines. In: Fogh, J. ed. Human tumor cell lines in vitro. New York: Plenum Press; 1975.
Golombick, T.; Bezwoda, W. R. In vitro maintenance of a new ovarian cancer cell line in protein-free media: a potential model for autonomous growth and tumor progression. Eur. J. Cell Biol. 56:459–463; 1991.
Golombick, T.; Dansey, R.; Bezwoda, W. R., et al. Establishment and characterization of two new human ovarian cancer cell lines UWOV1 and UWOV2 and a subline UWOV2(Sf) growing in serum-free conditions: growth characteristics, biochemical, and cytogenetic studies. In Vitro Cell. Dev. Biol. 26:447–454; 1990.
Grunt, T. W.; Oeller, H.; Somay C., et al. Different propensity for spontaneous differentiation of cell clones isolated from the human ovarian surface epithelial cell line HOC-7. Differentiation 53:45–50; 1993.
Gu, K.; Mes-Masson, A. M.; Gauthier, J., et al. Overexpression of her-2/neu in human prostate cancer and benign hyperplasia. Cancer Lett. 99: 185–189; 1996.
Gu, K.; Mes-Masson, A. M.; Gauthier, J., et al. Analysis of the p16 tumor suppressor gene in early-stage prostate cancer. Mol. Carcinogen. 21: 164–170; 1998.
Hamilton, T. C.; Young, R. C.; McKoy, W. M., et al. Characterization of a human ovarian carcinoma cell line (NIH:OVCAR-3) with androgen and estrogen receptors. Cancer Res. 43:5379–5389; 1983.
Hirte, H. W.; Kaiser, J. S.; Bacchetti, S. Establishment and characterization of four human epithelial ovarian carcinoma cell lines. Cancer 74: 9000–9006; 1994.
ISCN: An international system for human cytogenetics. In: Mitelman, F., ed. Nomenclature, Basel: Karger; 1995.
Langdon, S. P.; Lawrie, S. S.; Hay, F. G., et al. Characterization and properties of nine human ovarian adenocarcinoma cell lines. Cancer Res. 48: 6166–6172; 1988.
Lounis, H.; Mes-Masson, A.-M.; Dion, F., et al. Mapping of chromosome arm 3p deletions in unselected human epithelial ovarian cancers. Oncogene 17:2359–2366; 1998.
Lounis, H.; Provencher, D.; Godbout, C., et al. Primary cultures of normal and tumoral human ovarian epithelium: a powerful tool for basic molecular studies. Exp. Cell Res. 215:303–309; 1994.
Mattes, M. J.; Cairncross, J. G.; Old, L. J., et al. Monoclonal antibodies to three widely distributed human cell surface antigens. Hybridoma 2: 253–264; 1983.
Mattes, M. J.; Look, K.; Furukawa, K., et al. Mouse monoclonal antibodies to human epithelial differentiation antigens expressed on the surface of ovarian carcinoma ascites cells. Cancer Res. 47:6741–6750; 1987.
Mes-Masson, A. M.; Masson, S.; Banville, D., et al. Expression of oncomodulin does not lead to the transformation or immortalization of mammalian cells in vitro. J. Cell Sci. 94:517–525; 1989.
Morrow, C. P.; Curtin, J. P. Synopsis of gynecologic oncology. 5th ed. Philadelphia, PA: Churchill Livingstone; 1998.
Myeroff, L. L.; Parsons, R.; Kim, S. J., et al. A transforming growth factor beta receptor type II gene mutation common in colon and gastric but rare in endometrial cancers with microsatellite instability. Cancer Res. 55:5545–5547; 1995.
NCIC: Canadian cancer statistics 1999. Toronto, Canada: National Cancer Institute of Canada; 1999.
Provencher, D. M.; Finstad, C. L.; Saigo, P. E., et al. Comparison of antigen expression on fresh and cultured ascites cells and on solid tumors of patients with epithelial ovarian cancer. Gynecol. Oncol. 50:78–83; 1993.
Provencher, D. M.; Lounis, H.; Fink, D., et al. Discordance in p53 mutations when comparing ascites and solid tumors from patients with serous ovarian cancer. Tumor Biol. 18:167–174; 1997.
Serov, S. F.; Scully, R.; Sobin, L. H. Histological typing of ovarian tumours. In: W.H.O., ed. International histological classification of tumours. Vol. 9. Geneva: World Health Organization; 1973.
Sinna, G. A.; Beckman, G.; Lundgren, E., et al. Characterization of two human ovarian carcinoma cell lines. Gynecol. Oncol. 7:267–280; 1979.
Slamon, D. J.; Godolphin, W.; Jones, L. A., et al. Studies of the HER-2/neu proto-oncogene in human breast and ovarian cancer. Science 244: 707–712; 1989.
Thor, A.; Gorstein, F.; Ohuchi, N., et al. Tumor-associated glycoprotein (TAG-72) in ovarian carcinomas defined by monoclonal antibody B72.3. J. Natl. Cancer Inst. 76:995–1006; 1986.
Tonin, P. N.; Mes-Masson, A. M.; Futreal, P. A., et al. Founder BRCA1 and BRCA2 mutations in French Canadian breast and ovarian cancer families. Am. J. Hum. Genet. 63:1341–1351; 1998.
Whitman, G.; Nolan, T.; Gallup, D. Normal ovarian development and function. In: Markman, W. J. H., ed. Cancer of the ovary. New York, NY: Raven Press; 1993.
Wong, W. S.; Wong, Y. F.; Ng, Y. T., et al. Establishment and characterization of a new human cell line derived from ovarian clear cell carcinoma. Gynecol. Oncol. 38:37–45; 1990.
Wood, L. K.; Morgan, R. T.; Quinn, L. A., et al. Comparison of four new cell lines from patients with adenocarcinoma of the ovary. Cancer Res. 39:4449–4459; 1979.
Yamada, T.; Ueda, M.; Otsuki, Y., et al. Establishment and characterization of a cell line (OMC-3) originating from a human mucinous cystadenocarcinoma of the ovary. Gynecol. Oncol. 40:118–128; 1991.
Author information
Authors and Affiliations
Corresponding author
Additional information
These authors contributed equally to this paper.
Rights and permissions
About this article
Cite this article
Provencher, D.M., Lounis, H., Champoux, L. et al. Characterization of four novel epithelial ovarian cancer cell lines. In Vitro Cell.Dev.Biol.-Animal 36, 357–361 (2000). https://doi.org/10.1290/1071-2690(2000)036<0357:COFNEO>2.0.CO;2
Received:
Issue Date:
DOI: https://doi.org/10.1290/1071-2690(2000)036<0357:COFNEO>2.0.CO;2